Abnormalities in the regulation of prolactin in patients with chronic renal failure.

We have investigated the hypothalamic-hypophyseal regulation of prolactin secretion in patients with chronic renal failure treated with chronic hemodialysis. When compared to control subjects, baseline serum prolactin levels were elevated in the renal failure patients (range 11 to 16 mmicrogram/ml for renal failure patients, 6 to 9 mmicrogram/ml for controls, P less than 0.05). In addition, serum prolactin levels in the renal failure patients failed to suppress significantly following the administration of L-dopa, and did not increase in response to chlorpromazine or thyrotropin releasing hormone. These findings suggest an abnormal regulation of prolactin secretion and appear to be another example of the endocrine dysfunction that occurs in uremic subjects.

[1]  W. Jubiz,et al.  Thyroid dysfunction in uremia: evidence for thyroid and hypophyseal abnormalities. , 1976, Annals of internal medicine.

[2]  G. L. Noel,et al.  Effect of acute increases in serum triiodothyronine on TSH and prolactin responses to TRH, and estimates of pituitary stores of TSH and prolactin in normal subjects and in patients with primary hypothyroidism. , 1976, The Journal of clinical endocrinology and metabolism.

[3]  J. Clemens,et al.  The role of catecholamines in the release of anterior pituitary prolactin in vitro. , 1974, Endocrinology.

[4]  J. Takahara,et al.  Suppression of prolactin release by a purified porcine PIF preparation and catecholamines infused into a rat hypophysial portal vessel. , 1974, Endocrinology.

[5]  H. Friesen,et al.  Current understanding of human prolactin physiology and its diagnostic and therapeutic applications: a review. , 1974, American journal of obstetrics and gynecology.

[6]  G. Tolis,et al.  Functional evaluation of prolactin secretion in patients with hypothalamic-pituitary disorders. , 1973, The Journal of clinical investigation.

[7]  J. Wilber,et al.  Gynecomastia, prolactin, and other peptide hormones in patients undergoing chronic hemodialysis. , 1973, The Journal of clinical endocrinology and metabolism.

[8]  P. Hwang,et al.  A radioimmunoassay for human prolactin. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. C. Porter,et al.  Effect of anterior pituitary perfusion and intraventricular injection of catecholamines on prolactin release. , 1971, Endocrinology.

[10]  N. Christensen,et al.  Growth hormone in uremia. I. Plasma growth hormone, insulin and glucagon after oral and intravenous glucose in uremic subjects. , 1971, Scandinavian journal of clinical and laboratory investigation.

[11]  J. C. Porter,et al.  Effect of anterior pituitary perfusion and intraventricular injection of catecholamines and indoleamines on LH release. , 1970, Endocrinology.

[12]  R. Lawton,et al.  Gynecomastia: an endocrinologic complication of hemodialysis. , 1968, Annals of internal medicine.

[13]  A. Curtis,et al.  Gynecomastia; a review and an analysis of 160 cases. , 1954, Annals of internal medicine.